107.41
price up icon0.83%   0.88
after-market Handel nachbörslich: 107.62 0.21 +0.20%
loading
Schlusskurs vom Vortag:
$106.53
Offen:
$106.5
24-Stunden-Volumen:
7.00M
Relative Volume:
0.88
Marktkapitalisierung:
$147.06B
Einnahmen:
$17.55B
Nettoeinkommen (Verlust:
$2.03B
KGV:
78.40
EPS:
1.37
Netto-Cashflow:
$2.72B
1W Leistung:
+4.93%
1M Leistung:
+2.04%
6M Leistung:
+20.25%
1J Leistung:
+39.48%
1-Tages-Spanne:
Value
$106.25
$107.53
1-Wochen-Bereich:
Value
$102.05
$107.53
52-Wochen-Spanne:
Value
$71.88
$107.53

Boston Scientific Corp Stock (BSX) Company Profile

Name
Firmenname
Boston Scientific Corp
Name
Telefon
508-683-4000
Name
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Mitarbeiter
53,000
Name
Twitter
@bostonsci
Name
Nächster Verdiensttermin
2024-10-23
Name
Neueste SEC-Einreichungen
Name
BSX's Discussions on Twitter

Vergleichen Sie BSX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BSX
Boston Scientific Corp
107.41 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
ABT
Abbott Laboratories
136.01 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
SYK
Stryker Corp
395.63 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.17 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.21 44.46B 5.54B 4.18B 623.10M 7.00

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Eingeleitet Leerink Partners Outperform
2025-04-16 Hochstufung Needham Hold → Buy
2025-01-10 Hochstufung Deutsche Bank Hold → Buy
2024-10-18 Herabstufung Needham Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2024-02-01 Hochstufung Mizuho Neutral → Buy
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-06-30 Eingeleitet CL King Buy
2023-05-30 Fortgesetzt Morgan Stanley Overweight
2023-03-29 Eingeleitet UBS Buy
2022-12-22 Eingeleitet Mizuho Neutral
2022-12-20 Fortgesetzt Citigroup Buy
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-06 Eingeleitet Wolfe Research Outperform
2022-05-27 Hochstufung Needham Hold → Buy
2022-04-13 Fortgesetzt Truist Buy
2022-03-02 Fortgesetzt BofA Securities Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-05-26 Herabstufung Needham Buy → Hold
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Overweight
2020-09-17 Eingeleitet Truist Buy
2020-09-11 Eingeleitet Wolfe Research Peer Perform
2020-04-22 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-04-01 Hochstufung Goldman Neutral → Buy
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Buy
2019-12-30 Bestätigt Cowen Outperform
2019-12-19 Herabstufung Needham Strong Buy → Buy
2019-09-05 Fortgesetzt JP Morgan Overweight
2019-09-03 Fortgesetzt Barclays Overweight
2019-05-13 Hochstufung Evercore ISI In-line → Outperform
2018-11-28 Eingeleitet UBS Buy
2018-10-16 Eingeleitet Barclays Overweight
2018-10-02 Bestätigt Morgan Stanley Overweight
2018-09-07 Bestätigt Needham Strong Buy
2018-09-04 Hochstufung Jefferies Hold → Buy
2018-07-06 Bestätigt Needham Strong Buy
2018-06-27 Eingeleitet Bernstein Outperform
2018-04-26 Bestätigt Needham Strong Buy
Alle ansehen

Boston Scientific Corp Aktie (BSX) Neueste Nachrichten

pulisher
Jun 18, 2025

February 2026 Options Now Available For Boston Scientific (BSX) - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

Boston Scientific’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jun 18, 2025
pulisher
Jun 16, 2025

Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jun 16, 2025
pulisher
Jun 16, 2025

Boston Scientific (BSX) Receives Outperform Rating from Leerink Partners | BSX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Boston Scientific (BSX) Receives Outperform Rating from Analyst | BSX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 15, 2025

Does This Valuation Of Boston Scientific Corporation (NYSE:BSX) Imply Investors Are Overpaying? - Yahoo Finance

Jun 15, 2025
pulisher
Jun 13, 2025

Why the Market Dipped But Boston Scientific (BSX) Gained Today - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

Boston Scientific Shares Rally Over 1%, Highlighting Strong Long-Term Growth - Daily Chhattisgarh News

Jun 13, 2025
pulisher
Jun 13, 2025

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth? - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

What's the secret behind Boston Sci's successful product launches? - BioWorld MedTech

Jun 12, 2025
pulisher
Jun 12, 2025

Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029 - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 11, 2025

Five things: The Newbury GM, Zoominfo cuts, Vertex, Boston Scientific and casino night - The Business Journals

Jun 11, 2025
pulisher
Jun 10, 2025

Boston Scientific to sell 24-acre campus in Minnetonka - Finance & Commerce

Jun 10, 2025
pulisher
Jun 10, 2025

Boston Scientific is selling a Minnesota campus - MassDevice

Jun 10, 2025
pulisher
Jun 10, 2025

Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Boston Scientific lists 24-acre Minnesota campus for sale ahead of Maple Grove move - The Business Journals

Jun 10, 2025
pulisher
Jun 09, 2025

How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

Boston Scientific lists 24-acre Minnetonka campus for sale ahead of Maple Grove move - The Business Journals

Jun 09, 2025
pulisher
Jun 09, 2025

Boston Scientific Stock Slips Over 1% Amid Short-Term Pullback - Daily Chhattisgarh News

Jun 09, 2025
pulisher
Jun 06, 2025

Boston Scientific (BSX) Upgraded to Buy: Here's Why - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Boston Scientific’s EVP sells $5.8 million in stock By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 04, 2025

Boston Scientific’s EVP sells $5.8 million in stock - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Boston Scientific (NYSE:BSX) Secures US$30-45 Million Deal with Bittium for ECG Devices - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Emerging Markets Power Boston Scientific: Will The Growth Trend Continue? - Barchart.com

Jun 04, 2025
pulisher
Jun 04, 2025

Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Emerging Markets Power Boston Scientific: Will the Growth Trend Continue? - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

How Is Boston Scientific's Stock Performance Compared To Other Medical Device Stocks? - Barchart.com

Jun 03, 2025
pulisher
Jun 02, 2025

Rising obesity levels spur endoscopic sleeve uptick - BioWorld MedTech

Jun 02, 2025
pulisher
Jun 02, 2025

Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune

Jun 02, 2025
pulisher
May 31, 2025

Boston Scientific’s longtime DEI, HR leader exits for chief HR role at new company - MassDevice

May 31, 2025
pulisher
May 31, 2025

Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scienti - GuruFocus

May 31, 2025
pulisher
May 30, 2025

Before the Bell-Boston Scientific drops on profit miss - Reuters

May 30, 2025
pulisher
May 30, 2025

Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scientific Corp (BSX) - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Piper Sandler maintains Boston Scientific stock at Overweight - Investing.com

May 30, 2025
pulisher
May 29, 2025

Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World

May 29, 2025
pulisher
May 28, 2025

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga

May 28, 2025
pulisher
May 28, 2025

Boston Scientific ends TAVR sales; J&J shares Monarch robot data - MedTech Dive

May 28, 2025
pulisher
May 28, 2025

Boston Scientific (BSX) Ends Acurate TAVR Program, Shifts Focus to Promising Projects | BSX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

BSX: Analyst Reiterates Buy Rating for Boston Scientific | BSX S - GuruFocus

May 28, 2025
pulisher
May 28, 2025

In TAVR setback, Boston Sci pulls plug on Acurate valves - BioWorld MedTech

May 28, 2025
pulisher
May 28, 2025

Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden - MassDevice

May 28, 2025
pulisher
May 28, 2025

Boston Scientific Ends ACURATE Valve Sales By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Evercore ISI maintains Boston Scientific stock at Outperform - Investing.com

May 28, 2025
pulisher
May 28, 2025

TD Cowen maintains Boston Scientific stock at $115 target By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

TD Cowen maintains Boston Scientific stock at $115 target - Investing.com

May 28, 2025
pulisher
May 28, 2025

Boston Scientific (BSX) Discontinues Sales of ACURATE Aortic Valve Systems - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Boston Scientific (BSX) Discontinues Valve Product Amid Regulato - GuruFocus

May 28, 2025

Finanzdaten der Boston Scientific Corp-Aktie (BSX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Boston Scientific Corp-Aktie (BSX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Fitzgerald Joseph Michael
EVP & Group Pres, Cardiology
Jun 04 '25
Sale
102.88
56,372
5,799,630
178,342
medical_devices SYK
$395.63
price up icon 0.53%
medical_devices MDT
$87.17
price up icon 1.34%
medical_devices ABT
$136.01
price up icon 1.21%
medical_devices EW
$78.21
price up icon 0.00%
$74.07
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):